{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T11:46:04Z","timestamp":1791632764679,"version":"4.3.4"},"reference-count":139,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2020,1,29]],"date-time":"2020-01-29T00:00:00Z","timestamp":1580256000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>The most common malignant brain tumors are those of astrocytic origin, gliomas, with the most aggressive glioblastoma (WHO grade IV) among them. Despite efforts, medicine has not made progress in terms of the prognosis and life expectancy of glioma patients. Behind the malignant phenotype of gliomas lies multiple genetic mutations leading to reprogramming of their metabolism, which gives those highly proliferating cells an advantage over healthy ones. The so-called glutamine addiction is a metabolic adaptation that supplements oxidative glycolysis in order to secure neoplastic cells with nutrients and energy in unfavorable conditions of hypoxia. The present review aims at presenting the research and clinical attempts targeting the different metabolic pathways involved in glutamine metabolism in gliomas. A brief description of the biochemistry of glutamine transport, synthesis, and glutaminolysis, etc. will forego a detailed comparison of the therapeutic strategies undertaken to inhibit glutamine utilization by gliomas.<\/jats:p>","DOI":"10.3390\/cancers12020310","type":"journal-article","created":{"date-parts":[[2020,1,29]],"date-time":"2020-01-29T10:51:07Z","timestamp":1580295067000},"page":"310","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":93,"title":["Targeting Glutamine Addiction in Gliomas"],"prefix":"10.3390","volume":"12","author":[{"given":"Marta","family":"Obara-Michlewska","sequence":"first","affiliation":[{"name":"Department of Neurotoxicology, Mossakowski Medical Research Centre, Polish Academy of Sciences, 5 Pawi\u0144skiego Street, 02-106 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2973-4692","authenticated-orcid":false,"given":"Monika","family":"Szeliga","sequence":"additional","affiliation":[{"name":"Department of Neurotoxicology, Mossakowski Medical Research Centre, Polish Academy of Sciences, 5 Pawi\u0144skiego Street, 02-106 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,1,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1186\/s12986-016-0131-9","article-title":"Metabolic response of glioblastoma cells associated with glucose withdrawal and pyruvate substitution as revealed by GC-MS","volume":"13","author":"Oppermann","year":"2016","journal-title":"Nutr. Metab. (Lond.)"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/neuonc\/now128","article-title":"Fatty acid oxidation is required for the respiration and proliferation of malignant glioma cells","volume":"19","author":"Lin","year":"2017","journal-title":"Neuro Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0300-9084(96)89500-9","article-title":"Glucose and glutamine metabolism in C6 glioma cells studied by carbon 13 NMR","volume":"78","author":"Portais","year":"1996","journal-title":"Biochimie"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"19345","DOI":"10.1073\/pnas.0709747104","article-title":"Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis","volume":"104","author":"DeBerardinis","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e358","DOI":"10.1038\/s41419-019-1587-0","article-title":"R406 elicits anti-Warburg effect via Syk-dependent and -independent mechanisms to trigger apoptosis in glioma stem cells","volume":"10","author":"Sun","year":"2019","journal-title":"Cell Death Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.18632\/oncotarget.2708","article-title":"Mitochondrial p32 is upregulated in Myc expressing brain cancers and mediates glutamine addiction","volume":"6","author":"Fogal","year":"2015","journal-title":"Oncotarget"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"19721","DOI":"10.1074\/jbc.M117.814392","article-title":"Cystine uptake through the cystine\/glutamate antiporter xCT triggers glioblastoma cell death under glucose deprivation","volume":"292","author":"Goji","year":"2017","journal-title":"J. Biol. Chem."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/neuonc\/noz150","article-title":"CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012\u20132016","volume":"21","author":"Ostrom","year":"2019","journal-title":"Neuro Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1056\/NEJMoa0808710","article-title":"IDH1 and IDH2 mutations in gliomas","volume":"360","author":"Yan","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1093\/carcin\/bgz134","article-title":"Friend or foe-IDH1 mutations in glioma 10 years on","volume":"40","author":"Huang","year":"2019","journal-title":"Carcinogenesis"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"vii17","DOI":"10.1093\/neuonc\/noy158","article-title":"Updates in prognostic markers for gliomas","volume":"20","author":"Aquilanti","year":"2018","journal-title":"Neuro Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s11060-017-2379-y","article-title":"Molecular markers in glioma","volume":"134","author":"Ludwig","year":"2017","journal-title":"J. Neurooncol."},{"key":"ref_13","first-page":"5821","article-title":"Identification of a cancer stem cell in human brain tumors","volume":"63","author":"Singh","year":"2003","journal-title":"Cancer Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nature03128","article-title":"Identification of human brain tumour initiating cells","volume":"432","author":"Singh","year":"2004","journal-title":"Nature"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1101\/gad.324301.119","article-title":"Glioblastoma stem cells: Lessons from the tumor hierarchy in a lethal cancer","volume":"33","author":"Gimple","year":"2019","journal-title":"Genes Dev."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1590\/S0100-879X2003000200002","article-title":"Glutamine and glutamate as vital metabolites","volume":"36","author":"Newsholme","year":"2003","journal-title":"Braz. J. Med. Biol. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.cell.2008.11.044","article-title":"Bidirectional transport of amino acids regulates mTOR and autophagy","volume":"136","author":"Nicklin","year":"2009","journal-title":"Cell"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1471-4159.2006.03913.x","article-title":"The glutamate\/GABA-glutamine cycle: Aspects of transport, neurotransmitter homeostasis and ammonia transfer","volume":"98","author":"Bak","year":"2006","journal-title":"J. Neurochem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1017\/S1740925X11000093","article-title":"Roles of glutamine in neurotransmission","volume":"6","author":"Albrecht","year":"2010","journal-title":"Neuron Glia Biol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e107560","DOI":"10.1016\/j.neuropharm.2019.03.003","article-title":"Exchange-mode glutamine transport across CNS cell membranes","volume":"161","author":"Albrecht","year":"2019","journal-title":"Neuropharmacology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1126\/science.14400","article-title":"Glutamine synthetase: Glial localization in brain","volume":"195","author":"Bell","year":"1977","journal-title":"Science"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.neuint.2003.08.016","article-title":"Intercellular metabolic compartmentation in the brain: Past, present and future","volume":"45","author":"Hertz","year":"2004","journal-title":"Neurochem. Int."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Majewska, E., Marquez, J., Albrecht, J., and Szeliga, M. (2019). Transfection with GLS2 Glutaminase (GAB) Sensitizes Human Glioblastoma Cell Lines to Oxidative Stress by a Common Mechanism Involving Suppression of the PI3K\/AKT Pathway. Cancers, 11.","DOI":"10.3390\/cancers11010115"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"223","DOI":"10.4155\/fmc-2016-0190","article-title":"A tale of two glutaminases: Homologous enzymes with distinct roles in tumorigenesis","volume":"9","author":"Katt","year":"2017","journal-title":"Future Med. Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1369\/0022155414551177","article-title":"Determination of phosphate-activated glutaminase activity and its kinetics in mouse tissues using metabolic mapping (quantitative enzyme histochemistry)","volume":"62","author":"Botman","year":"2014","journal-title":"J. Histochem. Cytochem."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Martin-Rufian, M., Tosina, M., Campos-Sandoval, J.A., Manzanares, E., Lobo, C., Segura, J.A., Alonso, F.J., Mat\u00e9s, J.M., and M\u00e1rquez, J. (2012). Mammalian glutaminase Gls2 gene encodes two functional alternative transcripts by a surrogate promoter usage mechanism. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0038380"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/glia.22758","article-title":"Expression of Gls and Gls2 glutaminase isoforms in astrocytes","volume":"63","author":"Cardona","year":"2015","journal-title":"Glia"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s11064-010-0121-7","article-title":"The physical chemistry of brain and neural cell membranes: An overview","volume":"35","author":"Robertson","year":"2010","journal-title":"Neurochem. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"18782","DOI":"10.1073\/pnas.0810199105","article-title":"Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction","volume":"105","author":"Wise","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"eaau4972","DOI":"10.1126\/scitranslmed.aau4972","article-title":"Targeting pyrimidine synthesis accentuates molecular therapy response in glioblastoma stem cells","volume":"11","author":"Wang","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"8674","DOI":"10.1073\/pnas.1016627108","article-title":"Pyruvate carboxylase is required for glutamine-independent growth of tumor cells","volume":"108","author":"Cheng","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"850","DOI":"10.4161\/auto.24083","article-title":"Glutamate dehydrogenase contributes to leucine sensing in the regulation of autophagy","volume":"9","author":"Lorin","year":"2013","journal-title":"Autophagy"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Nayak, P., and Chatterjee, A.K. (2002). Response of regional brain glutamate transaminases of rat to aluminum in protein malnutrition. BMC Neurosci., 3.","DOI":"10.1186\/1471-2202-3-12"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"48081","DOI":"10.18632\/oncotarget.10129","article-title":"NRF2 and glutathione are key resistance mediators to temozolomide in glioma and melanoma cells","volume":"7","author":"Rocha","year":"2016","journal-title":"Oncotarget"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e3150145","DOI":"10.1155\/2019\/3150145","article-title":"Unraveling the Potential Role of Glutathione in Multiple Forms of Cell Death in Cancer Therapy","volume":"2019","author":"Lv","year":"2019","journal-title":"Oxid. Med. Cell Longev."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.canlet.2018.04.021","article-title":"Pseudolaric acid B triggers ferroptosis in glioma cells via activation of Nox4 and inhibition of xCT","volume":"428","author":"Wang","year":"2018","journal-title":"Cancer Lett."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1159\/000017324","article-title":"Evidence supporting the existence of an activity-dependent astrocyte-neuron lactate shuttle","volume":"20","author":"Pellerin","year":"1998","journal-title":"Dev. Neurosci."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e247","DOI":"10.1038\/s42003-019-0495-2","article-title":"Lactate from astrocytes fuels learning-induced mRNA translation in excitatory and inhibitory neurons","volume":"2","author":"Descalzi","year":"2019","journal-title":"Commun. Biol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.conb.2017.09.012","article-title":"Control of brain energy supply by astrocytes","volume":"47","author":"Nortley","year":"2017","journal-title":"Curr. Opin. Neurobiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e1759091418818261","DOI":"10.1177\/1759091418818261","article-title":"Mitochondrial Substrate-Level Phosphorylation as Energy Source for Glioblastoma: Review and Hypothesis","volume":"10","author":"Chinopoulos","year":"2018","journal-title":"ASN Neuro"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e1143","DOI":"10.3389\/fonc.2019.01143","article-title":"Lactate in the Regulation of Tumor Microenvironment and Therapeutic Approaches","volume":"9","year":"2019","journal-title":"Front Oncol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"8983","DOI":"10.1073\/pnas.1203244109","article-title":"Reprogramming of proline and glutamine metabolism contributes to the proliferative and metabolic responses regulated by oncogenic transcription factor c-MYC","volume":"109","author":"Liu","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1089\/ars.2017.7350","article-title":"Proline Metabolism in Cell Regulation and Cancer Biology: Recent Advances and Hypotheses","volume":"30","author":"Phang","year":"2019","journal-title":"Antioxid. Redox Signal."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1016\/j.celrep.2018.02.084","article-title":"Oncogenic IDH1 Mutations Promote Enhanced Proline Synthesis through PYCR1 to Support the Maintenance of Mitochondrial Redox Homeostasis","volume":"22","author":"Hollinshead","year":"2018","journal-title":"Cell Rep."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Cappelletti, P., Tallarita, E., Rabattoni, V., Campomenosi, P., Sacchi, S., and Pollegioni, L. (2018). Proline oxidase controls proline, glutamate, and glutamine cellular concentrations in a U87 glioblastoma cell line. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0196283"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Panosyan, E.H., Lin, H.J., Koster, J., and Lasky, J.L. (2017). In search of druggable targets for GBM amino acid metabolism. BMC Cancer., 17.","DOI":"10.1186\/s12885-017-3148-1"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Locasale, J.W., Melman, T., Song, S., Yang, X., Swanson, K.D., Cantley, L.C., Wong, E.T., and Asara, J.M. (2012). Metabolomics of human cerebrospinal fluid identifies signatures of malignant glioma. Mol. Cell Proteom., 11.","DOI":"10.1074\/mcp.M111.014688"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1186\/s13058-019-1141-0","article-title":"Glutamine to proline conversion is associated with response to glutaminase inhibition in breast cancer","volume":"21","author":"Grinde","year":"2019","journal-title":"Breast Cancer Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.cmet.2012.05.001","article-title":"Analysis of tumor metabolism reveals mitochondrial glucose oxidation in genetically diverse human glioblastomas in the mouse brain in vivo","volume":"15","author":"Yang","year":"2012","journal-title":"Cell Metab."},{"key":"ref_50","first-page":"605","article-title":"Epithelial membrane protein 1 promotes glioblastoma progression through the PI3K\/AKT\/mTOR signaling pathway","volume":"42","author":"Miao","year":"2019","journal-title":"Oncol. Rep."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"21496","DOI":"10.1074\/jbc.M116.734756","article-title":"Therapeutic Strategy for Targeting Aggressive Malignant Gliomas by Disrupting Their Energy Balance","volume":"291","author":"Hegazy","year":"2016","journal-title":"J. Biol. Chem."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40675-017-0062-7","article-title":"Hypoxia-Inducible Factors and Cancer","volume":"3","author":"Jun","year":"2017","journal-title":"Curr. Sleep Med. Rep."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.cmet.2013.09.013","article-title":"mTOR complex 2 controls glycolytic metabolism in glioblastoma through FoxO acetylation and upregulation of c-Myc","volume":"18","author":"Masui","year":"2013","journal-title":"Cell Metab."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"4452","DOI":"10.1158\/1078-0432.CCR-15-2274","article-title":"Myc-Driven Glycolysis Is a Therapeutic Target in Glioblastoma","volume":"22","author":"Tateishi","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/onc.2009.358","article-title":"Q\u2019s next: The diverse functions of glutamine in metabolism, cell biology and cancer","volume":"29","author":"DeBerardinis","year":"2010","journal-title":"Oncogene"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1002\/jcb.25488","article-title":"The Effects of Severe Hypoxia on Glycolytic Flux and Enzyme Activity in a Model of Solid Tumors","volume":"117","author":"Smith","year":"2016","journal-title":"J. Cell Biochem."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"7986","DOI":"10.1158\/0008-5472.CAN-09-2266","article-title":"Glioblastoma cells require glutamate dehydrogenase to survive impairments of glucose metabolism or Akt signaling","volume":"69","author":"Yang","year":"2009","journal-title":"Cancer Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1172\/JCI78239","article-title":"Compensatory glutamine metabolism promotes glioblastoma resistance to mTOR inhibitor treatment","volume":"125","author":"Tanaka","year":"2015","journal-title":"J. Clin. Investig."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"20164","DOI":"10.1074\/jbc.M111.337196","article-title":"1H NMR metabolomics analysis of glioblastoma subtypes: Correlation between metabolomics and gene expression characteristics","volume":"287","author":"Ferguson","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"6292","DOI":"10.1158\/1078-0432.CCR-16-3102","article-title":"Efficient Mitochondrial Glutamine Targeting Prevails Over Glioblastoma Metabolic Plasticity","volume":"23","author":"Oizel","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1038\/ncb3272","article-title":"Glutamine synthetase activity fuels nucleotide biosynthesis and supports growth of glutamine-restricted glioblastoma","volume":"17","author":"Tardito","year":"2015","journal-title":"Nat. Cell Biol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/nn.3510","article-title":"Brain tumor initiating cells adapt to restricted nutrition through preferential glucose uptake","volume":"16","author":"Flavahan","year":"2013","journal-title":"Nat. Neurosci."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"16062","DOI":"10.1073\/pnas.1106704108","article-title":"Metabolic state of glioma stem cells and nontumorigenic cells","volume":"108","author":"Vlashi","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.bbcan.2018.01.004","article-title":"The pro-tumorigenic effects of metabolic alterations in glioblastoma including brain tumor initiating cells","volume":"1869","author":"Libby","year":"2018","journal-title":"Biochim. Biophys. Acta Rev. Cancer."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1093\/neuonc\/nox170","article-title":"Metabolic heterogeneity and plasticity of glioma stem cells in a mouse glioblastoma model","volume":"20","author":"Shibao","year":"2018","journal-title":"Neuro Oncol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1148\/radiol.2533071654","article-title":"Untreated glioblastoma multiforme: Increased myo-inositol and glutamine levels in the contralateral cerebral hemisphere at proton MR spectroscopy","volume":"253","author":"Kallenberg","year":"2009","journal-title":"Radiology"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1021\/pr901088r","article-title":"Metabolomic patterns in glioblastoma and changes during radiotherapy: A clinical microdialysis study","volume":"9","author":"Wibom","year":"2010","journal-title":"J. Proteome Res."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"246","DOI":"10.4103\/0028-3886.177606","article-title":"Metabonomic signature analysis in plasma samples of glioma patients based on (1)H-nuclear magnetic resonance spectroscopy","volume":"64","author":"Kelimu","year":"2016","journal-title":"Neurol. India"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"20486","DOI":"10.18632\/oncotarget.7974","article-title":"Metabolomics profiling in plasma samples from glioma patients correlates with tumor phenotypes","volume":"7","author":"Zhao","year":"2016","journal-title":"Oncotarget"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1186\/s13014-016-0626-6","article-title":"Characterization of the serum metabolome following radiation treatment in patients with high-grade gliomas","volume":"11","author":"Wibom","year":"2016","journal-title":"Radiat. Oncol."},{"key":"ref_71","first-page":"4077","article-title":"Influence of glutamine on the growth of human glioma and medulloblastoma in culture","volume":"45","author":"Dranoff","year":"1985","journal-title":"Cancer Res."},{"key":"ref_72","first-page":"4082","article-title":"Combination chemotherapy in vitro exploiting glutamine metabolism of human glioma and medulloblastoma","volume":"45","author":"Dranoff","year":"1985","journal-title":"Cancer Res."},{"key":"ref_73","first-page":"125","article-title":"Neurological complications of antineoplastic therapy","volume":"100","author":"Shapiro","year":"1984","journal-title":"Acta Neurol. Scand. Suppl."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0163-7258(90)90094-I","article-title":"Metabolism and action of amino acid analog anti-cancer agents","volume":"46","author":"Ahluwalia","year":"1990","journal-title":"Pharmacol. Ther."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0197-0186(03)00040-8","article-title":"Glutamine transport in C6 glioma cells shows ASCT2 system characteristics","volume":"43","author":"Dybel","year":"2003","journal-title":"Neurochem. Int."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/00001756-200403220-00001","article-title":"Increased expression of a glutamine transporter SNAT3 is a marker of malignant gliomas","volume":"15","author":"Sidoryk","year":"2004","journal-title":"Neuroreport"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.neuint.2005.12.026","article-title":"Selective decrease of SN1(SNAT3) mRNA expression in human and rat glioma cells adapted to grow in acidic medium","volume":"48","author":"Sidoryk","year":"2006","journal-title":"Neurochem. Int."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1080\/14728222.2019.1627328","article-title":"ASCT2: A potential cancer drug target","volume":"23","author":"Wahi","year":"2019","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.neulet.2004.10.051","article-title":"Lack of expression of the liver-type glutaminase (LGA) mRNA in human malignant gliomas","volume":"374","author":"Szeliga","year":"2005","journal-title":"Neurosci. Lett."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"8981","DOI":"10.1158\/0008-5472.CAN-10-1666","article-title":"Inhibition of glutaminase preferentially slows growth of glioma cells with mutant IDH1","volume":"70","author":"Seltzer","year":"2010","journal-title":"Cancer Res."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.cell.2018.08.038","article-title":"Transaminase Inhibition by 2-Hydroxyglutarate Impairs Glutamate Biosynthesis and Redox Homeostasis in Glioma","volume":"175","author":"McBrayer","year":"2018","journal-title":"Cell"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00109-013-1105-2","article-title":"Both GLS silencing and GLS2 overexpression synergize with oxidative stress against proliferation of glioma cells","volume":"92","author":"Higuero","year":"2014","journal-title":"J. Mol. Med. (Berl.)"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1002\/ijc.29873","article-title":"Alterations in cellular metabolome after pharmacological inhibition of Notch in glioblastoma cells","volume":"138","author":"Kahlert","year":"2016","journal-title":"Int. J. Cancer"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.bbcan.2018.07.007","article-title":"Glutaminase isoenzymes in the metabolic therapy of cancer","volume":"1870","year":"2018","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/mc.22372","article-title":"Downregulation of GLS2 in glioblastoma cells is related to DNA hypermethylation but not to the p53 status","volume":"55","author":"Szeliga","year":"2016","journal-title":"Mol. Carcinog."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/glia.20825","article-title":"Transfection with liver-type glutaminase cDNA alters gene expression and reduces survival, migration and proliferation of T98G glioma cells","volume":"57","author":"Szeliga","year":"2009","journal-title":"Glia"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.neuint.2005.10.015","article-title":"Glutaminase: A multifaceted protein not only involved in generating glutamate","volume":"48","author":"Segura","year":"2006","journal-title":"Neurochem. Int."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1471-4159.2012.07917.x","article-title":"Transfection of a human glioblastoma cell line with liver-type glutaminase (LGA) down-regulates the expression of DNA-repair gene MGMT and sensitizes the cells to alkylating agents","volume":"123","author":"Szeliga","year":"2012","journal-title":"J. Neurochem."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"559","DOI":"10.3892\/ijo.2015.3271","article-title":"Sulforaphane reverses chemo-resistance to temozolomide in glioblastoma cells by NF-\u03baB-dependent pathway downregulating MGMT expression","volume":"48","author":"Lan","year":"2016","journal-title":"Int. J. Oncol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.18632\/oncotarget.1862","article-title":"Glutaminase 2 negatively regulates the PI3K\/AKT signaling and shows tumor suppression activity in human hepatocellular carcinoma","volume":"5","author":"Liu","year":"2014","journal-title":"Oncotarget"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1007\/s13277-013-1247-4","article-title":"Silencing of GLS and overexpression of GLS2 genes cooperate in decreasing the proliferation and viability of glioblastoma cells","volume":"35","author":"Szeliga","year":"2014","journal-title":"Tumour Biol."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Zhang, J., Wang, C., Chen, M., Cao, J., Zhong, Y., Chen, L., Shen, H.M., and Xia, D. (2013). Epigenetic silencing of glutaminase 2 in human liver and colon cancers. BMC Cancer, 13.","DOI":"10.1186\/1471-2407-13-601"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.canlet.2016.10.012","article-title":"Glutaminase 2 stabilizes Dicer to repress Snail and metastasis in hepatocellular carcinoma cells","volume":"383","author":"Kuo","year":"2016","journal-title":"Cancer Lett."},{"key":"ref_94","first-page":"4383","article-title":"Glioma cells release excitotoxic concentrations of glutamate","volume":"59","author":"Ye","year":"1999","journal-title":"Cancer Res."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"10767","DOI":"10.1523\/JNEUROSCI.19-24-10767.1999","article-title":"Compromised glutamate transport in human glioma cells: Reduction-mislocalization of sodium-dependent glutamate transporters and enhanced activity of cystine-glutamate exchange","volume":"19","author":"Ye","year":"1999","journal-title":"J. Neurosci."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1158\/0008-5472.CAN-04-3626","article-title":"The excitatory amino acid transporter-2 induces apoptosis and decreases glioma growth in vitro and in vivo","volume":"65","author":"Liu","year":"2005","journal-title":"Cancer Res."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1002\/ijc.31985","article-title":"Altered function of the glutamate-aspartate transporter GLAST, a potential therapeutic target in glioblastoma","volume":"144","author":"Corbetta","year":"2019","journal-title":"Int. J. Cancer"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/s41556-018-0118-z","article-title":"Aspartate is a limiting metabolite for cancer cell proliferation under hypoxia and in tumours","volume":"20","author":"Baudrier","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"884","DOI":"10.4161\/onci.20637","article-title":"Immunotherapy against the radial glia marker GLAST effectively triggers specific antitumor effectors without autoimmunity","volume":"1","author":"Cantini","year":"2012","journal-title":"Oncoimmunology"},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Robert, S.M., and Sontheimer, H. (2017). Peritumoral epilepsy. Reference Module in Neuroscience and Behavioral Psychology, Elsevier.","DOI":"10.1016\/B978-0-12-809324-5.00069-9"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.molcel.2017.05.030","article-title":"mTORC2 Regulates Amino Acid Metabolism in Cancer by Phosphorylation of the Cystine-Glutamate Antiporter xCT","volume":"67","author":"Gu","year":"2017","journal-title":"Mol. Cell"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/nm1772","article-title":"Small interfering RNA-mediated xCT silencing in gliomas inhibits neurodegeneration and alleviates brain edema","volume":"14","author":"Savaskan","year":"2008","journal-title":"Nat. Med."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"7101","DOI":"10.1523\/JNEUROSCI.5258-04.2005","article-title":"Inhibition of cystine uptake disrupts the growth of primary brain tumors","volume":"25","author":"Chung","year":"2005","journal-title":"J. Neurosci."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"9463","DOI":"10.1158\/0008-5472.CAN-07-2034","article-title":"Autocrine glutamate signaling promotes glioma cell invasion","volume":"67","author":"Lyons","year":"2007","journal-title":"Cancer Res."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1023\/A:1022106910017","article-title":"Baseline levels of glucose metabolites, glutamate and glycerol in malignant glioma assessed by stereotactic microdialysis","volume":"61","author":"Roslin","year":"2003","journal-title":"J. Neurooncol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/nbm.807","article-title":"Characterization of oligodendrogliomas using short echo time 1H MR spectroscopic imaging","volume":"16","author":"Rijpkema","year":"2003","journal-title":"NMR Biomed."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1471-4159.2008.05301.x","article-title":"A role for glutamate in growth and invasion of primary brain tumors","volume":"105","author":"Sontheimer","year":"2008","journal-title":"J. Neurochem."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Robe, P.A., Martin, D.H., Nguyen-Khac, M.T., Artesi, M., Deprez, M., Albert, A., Vanbelle, S., Califice, S., Bredel, M., and Bours, V. (2009). Early termination of ISRCTN45828668, a phase 1\/2 prospective, randomized study of sulfasalazine for the treatment of progressing malignant gliomas in adults. BMC Cancer, 9.","DOI":"10.1186\/1471-2407-9-372"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/nm.2453","article-title":"Glutamate release by primary brain tumors induces epileptic activity","volume":"17","author":"Buckingham","year":"2011","journal-title":"Nat. Med."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"5951","DOI":"10.1038\/onc.2015.60","article-title":"Drug repurposing: Sulfasalazine sensitizes gliomas to gamma knife radiosurgery by blocking cystine uptake through system Xc\u2212, leading to glutathione depletion","volume":"34","author":"Sleire","year":"2015","journal-title":"Oncogene"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"289ra86","DOI":"10.1126\/scitranslmed.aaa8103","article-title":"SLC7A11 expression is associated with seizures and predicts poor survival in patients with malignant glioma","volume":"7","author":"Robert","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.3892\/or.2015.3712","article-title":"Erastin sensitizes glioblastoma cells to temozolomide by restraining xCT and cystathionine-\u03b3-lyase function","volume":"33","author":"Chen","year":"2015","journal-title":"Oncol. Rep."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/ddr.21557","article-title":"Novel analogs of sulfasalazine as system Xc\u2212 antiporter inhibitors: Insights from the molecular modeling studies","volume":"80","author":"Patel","year":"2019","journal-title":"Drug Dev. Res."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.chembiol.2019.01.008","article-title":"Imidazole Ketone Erastin Induces Ferroptosis and Slows Tumor Growth in a Mouse Lymphoma Model","volume":"26","author":"Zhang","year":"2019","journal-title":"Cell Chem. Biol."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Mittra, E.S., Koglin, N., Mosci, C., Kumar, M., Hoehne, A., Keu, K.V., Iagaru, A.H., Mueller, A., Berndt, M., and Bullich, S. (2016). Pilot Preclinical and Clinical Evaluation of (4S)-4-(3-[18F]Fluoropropyl)-L-Glutamate (18F-FSPG) for PET\/CT Imaging of Intracranial Malignancies. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0148628"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1365-2990.1990.tb01157.x","article-title":"A study of glutamine synthetase in normal human brain and intracranial tumours","volume":"16","author":"McCormick","year":"1990","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"789","DOI":"10.3171\/2011.5.JNS11451","article-title":"Proteomic identification of glutamine synthetase as a differential marker for oligodendrogliomas and astrocytomas","volume":"115","author":"Zhuang","year":"2011","journal-title":"J. Neurosurg."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s11060-008-9794-z","article-title":"Epilepsy in glioblastoma multiforme: Correlation with glutamine synthetase levels","volume":"93","author":"Rosati","year":"2009","journal-title":"J. Neurooncol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/neuonc\/nos338","article-title":"Glutamine synthetase expression as a valuable marker of epilepsy and longer survival in newly diagnosed glioblastoma multiforme","volume":"15","author":"Rosati","year":"2013","journal-title":"Neuro Oncol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11060-013-1168-5","article-title":"Glutamine synthetase functions as a negative growth regulator in glioma","volume":"114","author":"Yin","year":"2013","journal-title":"J. Neurooncol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"14217","DOI":"10.1073\/pnas.1409653111","article-title":"Hominoid-specific enzyme GLUD2 promotes growth of IDH1R132H glioma","volume":"111","author":"Chen","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ebiom.2018.10.008","article-title":"Mitochondrial enzyme GLUD2 plays a critical role in glioblastoma progression","volume":"37","author":"Franceschi","year":"2018","journal-title":"EBioMedicine"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1158\/0008-5472.CAN-18-3726","article-title":"The Tumor Metabolic Microenvironment: Lessons from Lactate","volume":"79","author":"Chen","year":"2019","journal-title":"Cancer Res."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/cdd.2010.150","article-title":"Acidic stress promotes a glioma stem cell phenotype","volume":"18","author":"Hjelmeland","year":"2011","journal-title":"Cell Death Differ."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"e7865","DOI":"10.1038\/s41598-017-07609-7","article-title":"Temozolomide arrests glioma growth and normalizes intratumoral extracellular pH","volume":"7","author":"Rao","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"e3849373","DOI":"10.1155\/2017\/3849373","article-title":"Mapping Extracellular pH of Gliomas in Presence of Superparamagnetic Nanoparticles: Towards Imaging the Distribution of Drug-Containing Nanoparticles and Their Curative Effect on the Tumor Microenvironment","volume":"2017","author":"Maritim","year":"2017","journal-title":"Contrast Media Mol. Imaging"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"46","DOI":"10.18383\/j.tom.2018.00001","article-title":"Longitudinal Measurements of Intra- and Extracellular pH Gradient in a Rat Model of Glioma","volume":"4","author":"Lim","year":"2018","journal-title":"Tomography"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1186\/1475-2867-13-89","article-title":"Acidic extracellular microenvironment and cancer","volume":"13","author":"Kato","year":"2013","journal-title":"Cancer Cell Int."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s10059-010-0067-2","article-title":"HIF-1 and HIF-2 transcription factors\u2014Similar but not identical","volume":"29","author":"Loboda","year":"2010","journal-title":"Mol. Cells"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1080\/15384101.2015.1120930","article-title":"Lactate promotes glutamine uptake and metabolism in oxidative cancer cells","volume":"15","author":"Dadhich","year":"2016","journal-title":"Cell Cycle"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0197-0186(93)90004-O","article-title":"Changes in lactate dehydrogenase isoenzyme pattern in patients with tumors of the central nervous system","volume":"22","author":"Subhash","year":"1993","journal-title":"Neurochem. Int."},{"key":"ref_132","first-page":"5131","article-title":"Silencing LDHA inhibits proliferation, induces apoptosis and increases chemosensitivity to temozolomide in glioma cells","volume":"15","author":"Di","year":"2018","journal-title":"Oncol. Lett."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"544","DOI":"10.7150\/ijbs.30297","article-title":"Cyclin G2 Inhibits the Warburg Effect and Tumour Progression by Suppressing LDHA Phosphorylation in Glioma","volume":"15","author":"Li","year":"2019","journal-title":"Int. J. Biol. Sci."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"e15556","DOI":"10.1038\/srep15556","article-title":"Lactate dehydrogenase-A inhibition induces human glioblastoma multiforme stem cell differentiation and death","volume":"5","author":"Daniele","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1227\/00006123-199409000-00012","article-title":"Detection and quantification of vascular endothelial growth factor\/vascular permeability factor in brain tumor tissue and cyst fluid: The key to angiogenesis?","volume":"35","author":"Weindel","year":"1994","journal-title":"Neurosurgery"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/00000478-199807000-00004","article-title":"Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma, and ependymoma","volume":"22","author":"Chan","year":"1998","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_137","first-page":"6020","article-title":"Hypoxia and acidosis independently up-regulate vascular endothelial growth factor transcription in brain tumors in vivo","volume":"61","author":"Fukumura","year":"2001","journal-title":"Cancer Res."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"11368","DOI":"10.1074\/jbc.M108347200","article-title":"Acidic extracellular pH induces vascular endothelial growth factor (VEGF) in human glioblastoma cells via ERK1\/2 MAPK signaling pathway: Mechanism of low pH-induced VEGF","volume":"277","author":"Xu","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"414","DOI":"10.6004\/jnccn.2011.0038","article-title":"A review of VEGF\/VEGFR-targeted therapeutics for recurrent glioblastoma","volume":"9","author":"Reardon","year":"2011","journal-title":"J. Natl. Compr. Cancer Netw."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/12\/2\/310\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:44:43Z","timestamp":1760363083000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/12\/2\/310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,29]]},"references-count":139,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,2]]}},"alternative-id":["cancers12020310"],"URL":"https:\/\/doi.org\/10.3390\/cancers12020310","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,29]]}}}